Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Weitere Synonyme anzeigen
Mouse (Murine) Polyclonal CXCL5 Primary Antibody für IF (p), IHC (p) - ABIN741900
Heilmann, Schinke, Bindl, Wehner, Rapp, Haffner-Luntzer, Nemitz, Liedert, Amling, Ignatius: The Wnt serpentine receptor Frizzled-9 regulates new bone formation in fracture healing. in PLoS ONE 2014
Show all 5 Pubmed References
Human Monoclonal CXCL5 Primary Antibody für IHC (p), ELISA - ABIN562826
Zhou, Dai, Zhou, Wang, Yang, Wang, Huang, Fan, Zhou: Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. in Hepatology (Baltimore, Md.) 2012
Show all 3 Pubmed References
Human Monoclonal CXCL5 Primary Antibody für CyTOF, ELISA (Capture) - ABIN4900299
Edwards, Johnson, Johnston: Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells. in American journal of respiratory cell and molecular biology 2006
Human Polyclonal CXCL5 Primary Antibody für ELISA, WB - ABIN2473135
Strieter, Belperio, Phillips, Keane: CXC chemokines in angiogenesis of cancer. in Seminars in cancer biology 2004
PERK (zeige EIF2AK3 Antikörper)-p-eIF2alpha (zeige EIF2A Antikörper) pathway could suppress metastasis in triple-negative breast cancer by inhibiting expression of PDL1 (zeige CD274 Antikörper) and CXCL5 in tumor cells.
Mechanistically, AR modulated cytokine CXCL5 expression by altering AKT (zeige AKT1 Antikörper) --> NF-kappaB (zeige NFKB1 Antikörper) signaling, and interruption of AKT (zeige AKT1 Antikörper) --> NF-kappaB (zeige NFKB1 Antikörper) --> CXCL5 signaling using either specific inhibitors or siRNA suppressed AR-enhanced EC recruitment and AR-EC-promoted RCC (zeige XRCC1 Antikörper) progression.
Curcumin suppressed CXCL5 expression by direct inhibition of IKKbeta (zeige IKBKB Antikörper) phosphorylation, and inhibition of p38 MAPK (zeige MAPK14 Antikörper) via induction of negative regulator MKP-1 (zeige DUSP1 Antikörper).
The CXCL5 and the overexpression of miR (zeige MLXIP Antikörper)-141 reduced levels of MMP-2 (zeige MMP2 Antikörper) and MMP-9 (zeige MMP9 Antikörper) in tumor necrosis factor-alpha (zeige TNF Antikörper)-treated HT29 cells by means of repressing the inhibitory AKT (zeige AKT1 Antikörper).
CXCL5 may promote mitomycin resistance by activating EMT (zeige ITK Antikörper) and NF-kappaB (zeige NFKB1 Antikörper) pathway. Thus, this study identifies CXCL5 as a novel chemoresistance-related marker in non-muscle invasive bladder cancer
findings for the first time provided evidence that ENA78 may play a key role of mediator in pathogenesis of Major Depressive Disorder(MDD) and in the mechanism of vinlafaxine effects on MDD.
Two haplotype blocks, one upstream to the coding region of UGT2A1 (rs146712414, P = 9.1 x 10(-5); odds ratio [OR], 1.34; 95% confidence interval [CI], 1.16-1.56) and one downstream of the genes PF4/PPBP/CXCL5 (rs1595009, P = 1.3 x 10(-4); OR, 1.32; 95% CI, 1.15-1.52), were associated with AgP.
our findings support CXCL5 as a promoter of colorectal cancer metastasis and a predictor of poor clinical outcomes in colorectal cancer patients.
CXCL5 levels were decreased in LSCC patient serum.
a finely tuned balance between the GAG-bound dimer and free soluble monomer regulates CXCL5-mediated receptor signaling and function.
Identify Cxcl5 as a novel target of AHR (zeige AHR Antikörper)-mediated gene expression in primary mouse keratinocytes.
Parenchymal polymorphonuclear myeloid-derived suppressor cell (PMN (zeige TBCE Antikörper)-MDSC), have a positive correlation with IL1a (zeige IL1A Antikörper), IL8 (zeige IL8 Antikörper), CXCL5, and Mip-1a (zeige CCL3 Antikörper), suggesting they may attract PMN (zeige TBCE Antikörper)-MDSC into the tumor
These data identify suppression of CXCL2 (zeige CXCL2 Antikörper) and CXCL5 chemoattractant expression by 11beta-HSD1 (zeige HSD11B1 Antikörper) as a novel mechanism with potential for regulation of neutrophil recruitment to the injured myocardium, and cardiac fibroblasts as a key site for intracellular glucocorticoid regeneration during acute inflammation following myocardial injury.
IL-17RA (zeige IL17RA Antikörper) regulates CXL-1 and 5 production in the lungs during the adaptive response.
STAT3 (zeige STAT3 Antikörper) is required for maximal OSM (zeige OSM Antikörper)-induced CXCL5 expression.
CXCL5 has a role in neutrophil recruitment in TH17-mediated glomerulonephritis
Since adaptive villus growth occurs despite impaired CXCL5 expression and enhanced angiogenesis, this suggests that the growth of new blood vessels is not needed for resection-induced mucosal surface area expansion following massive SBR (zeige NXF1 Antikörper).
CXCL5 regulates pulmonary responses to infection and plays a central role in conferring clock control of inflammation.
findings demonstrated that CXCL1 (zeige CXCL1 Antikörper) and CXCL5 are increased in circulation with onset of T2D, are produced by islets under stress, and synergistically affect islet function, suggesting that these chemokines participate in pathogenesis of T2D.
TLR2-induced epithelial-derived CXCL5 is critical for polymorphonuclear leukocyte-driven destructive inflammation in pulmonary tuberculosis.
The protein encoded by this gene is an inflammatory chemokine that belongs to the CXC chemokine family. This chemokine is produced concomitantly with interleukin-8 (IL8) in response to stimulation with either interleukin-1 (IL1) or tumor necrosis factor-alpha (TNFA). This chemokine is a potent chemotaxin involved in neutrophil activation.
C-X-C motif chemokine 5
, epithelial-derived neutrophil-activating protein 78
, neutrophil-activating peptide ENA-78
, neutrophil-activating protein 78
, small inducible cytokine subfamily B (Cys-X-Cys), member 5 (epithelial-derived neutrophil-activating peptide 78)
, CXC chemokine LIX
, chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2)
, cytokine LIX
, small-inducible cytokine B5
, C-X-C motif chemokine 6
, chemokine (C-X-C motif) ligand 5
, granulocyte chemotactic protein 2
, inducible cytokine subfamily B (Cys-X-Cys), member 6
, small-inducible cytokine B6
, granulocyte chemotactic protein-2
, small inducible cytokine B subfamily, member 5
, small inducible cytokine subfamily B, member 15